News

PharmTech8h
China’s NMPA Approves Merck KGaA Treatment for Tenosynovial Giant Cell Tumor
NMPA’s Center for Drug Evaluation accepted Merck KGaA’s application for marketing authorization of pimicotinib as a Class 1 ...
PharmTech15h
Implications of RFK Jr.’s CDC Vaccine Committee Overhaul for the Pharmaceutical Industry
The dismissal of all 17 members of the Advisory Committee on Immunization Practices has far-reaching impacts for the industry ...